MSM vs OMAB

MSM exhibits strong fundamental health with a Piotroski F-Score of 8/9 and low leverage (Debt/Equity 0.40), yet it is severely overvalued relative to its deterministic baselines. The current price of $100.75 trades at a significant premium to both the Graham Number ($45.55) and the Intrinsic Value ($74.03). While the company has a consistent history of earnings beats, sluggish revenue growth (2.9%) and an unsustainable dividend payout ratio (92.47%) limit further upside. The stock is currently in a 'valuation trap' where strong balance sheet health is offset by expensive multiples and stagnant growth.

OMAB exhibits a stable financial profile with a Piotroski F-Score of 6/9, though it currently trades at a significant premium to its Graham Number ($44.01) and Intrinsic Value ($69.43). The company possesses elite operational efficiency, evidenced by a 51.8% operating margin and a 48.84% ROE, which justifies some of the valuation premium. However, the combination of a bearish technical trend (0/100), flat YoY revenue growth, and a high dividend payout ratio (83.37%) suggests limited immediate upside. While fundamentally a high-quality 'cash cow,' the current entry price is decoupled from deterministic value baselines.